Neurocrine Biosciences
NBIX
#1210
Rank
C$21.98 B
Marketcap
$217.17
Share price
-0.02%
Change (1 day)
13.86%
Change (1 year)
Neurocrine Biosciences is an American biopharmaceutical company that develops treatments for neurological and endocrine-related diseases and disorders.

We have found no dividend history for this company